Colgate-Palmolive Company (CL)

NYSE: CL · USD

$91.6

-0.61 (-0.7%)· Recorded snapshot

영어 원본으로 대체KO

번역하는 동안 영어 원본을 표시 중

이 리포트는 아직 번역되지 않았습니다. 번역 대기열이 따라잡으면 몇 분 후에 새로고침하세요.

StockMarketAgent Research · Analyzed 2026-09-27

Our latest published analysis: CL rated Reduce

Colgate-Palmolive Company's published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$74.0 / share

Potential value

$102 / share

Upside to FV

-14.0%

from $91.6

Moat

9/10

Wide

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$68.6B
Revenue (ttm)	21B
Net income (ttm)	2B
EPS (ttm)	$2.53
Shares out	797.2M
P/E (trailing)	36.1x
P/E (forward)	21.0x
Dividend	$2.12 (2.32%)
Volume	2,983,423
Beta	0.32

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 21B
Net income (ttm): 2B
EPS (ttm): $2.53
P/E (trailing): 36.1x
P/E (forward): 21.0x
Market cap: $68.6B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$17.42B	$17.97B	$19.46B	$20.10B	$20.38B	+4.0%
Gross profit	$10.38B	$10.25B	$11.33B	$12.16B	$12.25B	+4.2%
Operating income	$3.33B	$2.89B	$3.98B	$4.27B	$3.31B	-0.2%
Net income	$2.17B	$1.79B	$2.30B	$2.89B	$2.13B	-0.4%
EPS (diluted)	$2.55	$2.13	$2.77	$3.51	$2.63	+0.8%
EBITDA	$3.76B	$3.37B	$4.25B	$4.85B	$3.96B	+1.3%
R&D	$307.0M	$320.0M	$343.0M	$355.0M	$366.0M	+4.5%
SG&A	$6.41B	$6.57B	$7.15B	$7.73B	$7.90B	+5.4%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ABBV	AbbVie Inc.	505.6B	80.8x	7.9x	17.7%	+3.7%	+29.1%	매도
ABT	Abbott Laboratories	177.6B	38.2x	3.7x	7.2%	+2.7%	-17.2%	비중 축소
ACN	Accenture plc	144.3B	18.0x	2.0x	27.9%	+8.0%	+0.4%	보유
ADM	Archer-Daniels-Midland Company	37.3B	21.2x	0.5x	5.0%	+1.8%	+28.5%	비중 축소
BF.B	Brown-Forman Corporation Class B	12.7B	17.9x	3.3x	14.3%	+1.6%	+0.4%	매수
CAG	Conagra Brands, Inc.	6.6B	—	0.6x	9.2%	+0.2%	-18.9%	적극 매수

Base and Bull scenarios

Base60%

Price target

$74.00

-14.0% from spot

In the base outcome, yielding $74.00 with an estimated probability of 60.0% and an expected return of -14.0%, Colgate-Palmolive delivers steady organic growth across its core franchises. Mass merchant channel inventory stabilizes, and gross profit gains are balanced by necessary advertising reinvestment to maintain defensive market share. However, because $86.06 trades above Fair value of $74.00, the expected return profile remains negative at -14.0%, validating a Reduce recommendation.

Oral care volume and pricing compound at normalized mature consumption rates
Consolidated gross margins hold steady near recent expanded levels
Operating margins recover toward long-term normalized targets over the medium term
Disciplined capital expenditures and steady working capital support high cash conversion

Bull15%

Price target

$101.51

+18.0% from spot

In the bull outcome, projected at $101.51 with an estimated probability of 15.0% and an expected return of 18.0%, Colgate-Palmolive accelerates international oral care premiumization while Hill's Pet Nutrition expands veterinary market share globally. Gross margin gains outpace cost inflation, allowing operating margins to surpass historical peaks even after funding strong commercial marketing. This scenario would be disconfirmed if retail partners resist premium shelf allocation or if emerging market currency devaluations erode reported sales gains.

Accelerated premiumization in Pet Nutrition and international oral care driving sustained above-trend revenue growth
Gross margin expansion supported by supply-chain productivity savings and benign commodity input costs
Operating margins expanding past prior historical peak levels as commercial advertising delivers positive operating leverage
Terminal price-to-earnings valuation multiple expanding on premium brand positioning

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($74.00). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	2.0%	2.3%	2.5%	2.8%	3.0%
6.2%	$84.2	$87.5	$91.4	$95.8	$101
6.7%	$76.2	$78.8	$81.6	$84.8	$88.5
7.2%	$69.9	$71.8	$74.0	$76.4	$79.1
7.7%	$64.7	$66.2	$67.9	$69.8	$71.9
8.2%	$60.3	$61.5	$62.9	$64.4	$66.0

Scorecard

Published factor rows and weighted composite

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E21

P25 n/aP50 n/aP75 n/a

Trailing P/E33.9

P25 n/aP50 n/aP75 n/a

ROE267.4

P25 n/aP50 n/aP75 n/a

ROIC45.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CL indicators

Market & fundamental data

Available fields

289

Groups with data

Currency

USD

Showing 289 of 289 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000021665
Company name	Colgate-Palmolive Company
Country	United States
Country code	US
CUSIP number	194162103
Earnings date	2026-10-30
Earnings time	bmo
Employees	33,600
Employees change	-400
Employees growth	-1.18%
Enterprise value	$79.4B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1806
In index	SP500
Industry	Household & Personal Products
Is primary listing	Yes
Is SPAC	No
ISIN number	US1941621039
Last 10-K release date	2026-02-23
Last earnings date	2026-07-31
Last refreshed	2026-10-28
Last stock split date	2013-05-16
Last stock split type	Forward
Market cap	$73B
Market cap category	Large-Cap
Next earnings date	2026-10-30
Options	Yes
Price	$91.56
Price currency	USD
Sector	Consumer Staples
SIC code	2844
Stock price date	2026-10-28
Symbol	CL
U.S. state	New York
Website	https://www.colgatepalmolive.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	23.97x
Average P/E ratio (10Y)	29.14x
Average P/E ratio (3Y)	29.14x
Average P/E ratio (5Y)	31.08x
Earnings yield	2.77%
EV/Earnings	39.06x
EV/EBIT	18.34x
EV/EBITDA	15.97x
EV/FCF	20.63x
EV/Sales	3.78x
FCF / EV yield	4.85%
FCF yield	5.27%
Forward EV/Sales	3.67x
Forward P/E	23.37x
Forward P/S	3.37x
Graham number	4.10865
Graham upside	-95.53%
Industry forward P/E	20.3x
Industry P/E	23.19x
Lynch fair value	$12.67
Lynch upside	-86.2%
P/(FCF - SBC) ratio	19.89x
P/(OCF - SBC) ratio	17.11x
P/B ratio	129.32x
P/E ratio	36.13x
P/FCF ratio	18.97x
P/OCF ratio	16.43x
P/S ratio	3.48x
PEG ratio	4.71x
Price/EBITDA ratio	14.69x
Sector forward P/E	21.33x
Sector P/E	28.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	20.63%
EBITDA margin	23.68%
Effective tax rate	26.48%
FCF margin	18.33%
Gross margin	60.43%
Operating margin	20.63%
Pretax margin	13.98%
Profit margin	9.68%
Profit per employee	$60,655
Profitable quarters	2
Profitable years	35
Revenue per employee	$626,399
ROA	15.84%
ROA (5Y)	15.58%
ROCE	40.79%
ROE	267.37%
ROE (5Y)	325.86%
ROIC	45.56%
ROIC (5Y)	35.6%
SBC / revenue	0.85%
Tax / revenue	3.7%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-28.82%
EPS growth (Q)	-5.5%
EPS growth (QoQ)	7.5%
EPS growth 10Y	5.02%
EPS growth 3Y	12.14%
EPS growth 5Y	-4.56%
EPS growth years	0
FCF growth	14.48%
FCF growth (Q)	11.73%
FCF growth (QoQ)	42.36%
FCF growth 3Y	17.87%
FCF growth 5Y	7.7%
Gross profit growth	4.92%
Gross profit growth (Q)	7.46%
Gross profit growth 3Y	6.19%
Gross profit growth 5Y	4.16%
Net income growth	-29.92%
Net income growth (Q)	-6.73%
Net income growth (QoQ)	7.28%
Net income growth 3Y	10.83%
Net income growth 5Y	-5.67%
Net income growth years	0
OCF growth	13.67%
OCF growth (Q)	12.56%
OCF growth (QoQ)	33.2%
OCF growth 10Y	3.88%
OCF growth 3Y	12.87%
OCF growth 5Y	7.18%
Operating income growth	2.7%
Operating income growth (Q)	5.44%
Operating income growth 3Y	5.69%
Operating income growth 5Y	2.22%
Revenue growth	5.25%
Revenue growth (Q)	4.91%
Revenue growth (QoQ)	0.69%
Revenue growth 10Y	3.1%
Revenue growth 3Y	4.06%
Revenue growth 5Y	4.26%
Revenue growth quarters	5
Revenue growth years	9

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-598M
Depreciation and amortization	$642M
EBIT	$4.3B
EBITDA	$5B
EPS	$2.53
FCF per share	$4.84
Financing cash flow	$-3.8B
Free cash flow	$3.9B
Free cash flow minus SBC	$3.7B
Gross profit	$12.7B
Income taxes	$779M
Investing cash flow	$-501M
Net borrowing	$-817M
Net cash flow	$155M
Net income	$2B
Operating cash flow minus SBC	$4.3B
Operating income	$4.3B
Revenue	$21B
Stock-based compensation	$178M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	6.91
Book value per share	$0.30
Debt / EBITDA	1.53
Debt / equity	13.88
Debt / FCF	2.04
Goodwill	$3.1B
Interest coverage	17.09
Long-term assets	$10.5B
Long-term liabilities	$10.1B
Net cash (debt)	$-6.4B
Net cash / market cap	-8.75%
Net debt / EBITDA	1.29
Net debt / equity	11.31
Net debt / FCF	1.66
Piotroski F-Score	6
Property, plant and equipment	$4.6B
Shareholders' equity	$566M
Tangible book value	$-4.4B
Tangible book value per share	$-5.47
Total assets	$16.8B
Total cash	$1.5B
Total debt	$7.9B
Total liabilities	$16.2B
WACC	5.67%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.23
Current assets	$6.3B
Current liabilities	$6.1B
Current ratio	1.03
Inventory turnover	3.87
Net working capital	$-1.3B
Quick ratio	0.56
Working capital	$160M
Working capital turnover	-68

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.49%
Dividend growth	2.43%
Dividend growth (10Y)	3.13%
Dividend growth (3Y)	3.38%
Dividend growth (5Y)	3.34%
Dividend growth years	63
Dividend payment date	2026-11-13
Dividend payment years	63
Dividend payout frequency	Quarterly
Dividend per share	$2.12
Dividend yield	2.32%
Ex-dividend date	2026-10-20
FCF payout ratio	43.81%
Last dividend	$0.53
Payout ratio	83.65%
Shareholder yield	3.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	29.47%
10Y return CAGR	5.07%
10Y total return	63.98%
150-day SMA	$89.14
15Y price change	100.09%
15Y return CAGR	7.2%
15Y total return	183.66%
1D price change	-0.66%
1M price change	6.17%
1M total return	6.78%
1W price change	-3.35%
1W total return	-3.35%
1Y price change	17.4%
1Y return CAGR	20.23%
1Y total return	20.21%
20-day SMA	$90.74
200-day SMA	$89.58
20Y price change	188.64%
20Y return CAGR	7.94%
20Y total return	361.29%
3M price change	-0.66%
3M total return	-0.1%
3Y price change	27.27%
3Y return CAGR	10.91%
3Y total return	36.42%
50-day SMA	$89.39
50-day SMA vs 200-day SMA	50under200
52-week high	$99.33
52-week high date	2026-02-27
52-week low	$74.55
52-week low date	2025-11-03
5Y price change	20.38%
5Y return CAGR	6.28%
5Y total return	35.58%
6M price change	8.55%
6M total return	9.8%
All-time high	$109.30
All-time high date	2024-09-05
All-time low	$0.66
All-time low date	1970-05-26
Average true range (ATR)	$1.85
Average volume	4.6M
Beta (1Y)	0.19
Beta (2Y)	0.16
Beta (5Y)	0.32
Change from 52-week high	-7.82%
Change from 52-week low	22.83%
Change from all-time high	-16.4%
Change from all-time low	13,821.99%
Change from open	0.6%
Day's gap	-1.26%
Dollar volume	$273.2M
High price	$92.16
Low price	$90.61
Monthly RSI	53.28
Open price	$91.01
Position in 52-week range	61.29%
Premarket change	-1.27%
Premarket close	$92.17
Premarket price	$91.00
Premarket volume	6.6K
Previous close	$92.17
Price vs 150-day SMA	2.5%
Price vs 20-day SMA	0.7%
Price vs 200-day SMA	2%
Price vs 50-day SMA	2.21%
Relative volume	0.64
RSI	51.37
Sharpe ratio	0.74
Sharpe ratio (3Y)	0.41
Sharpe ratio (5Y)	0.22
Sortino ratio	1.4
Sortino ratio (3Y)	0.89
Sortino ratio (5Y)	0.6
Volume	3M
Weekly RSI	53.86
YTD price change	15.63%
YTD total return	18.4%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	748.4M
Float percentage	93.88%
Shares change (QoQ)	-0.41%
Shares change (YoY)	-1.49%
Shares held by insiders	0.13%
Shares held by institutions	85.79%
Shares outstanding	797.2M
Short % of float	3.21%
Short % of shares	3.02%
Short ratio	4.5 days

Deeper analysis on CL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Quote this valuation with its source: Fair value, Potential value and the price at analysis.

Frequently asked questions

About this CL report

What is the latest published CL stock rating?

Colgate-Palmolive Company is shown with Reduce in the latest published report, analyzed 2026-09-27. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CL analysis?

The full latest published report, analyzed 2026-09-27, lives at /stocks/CL/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for CL?

The latest published report analyzed 2026-09-27 gives CL a fair value of USD 74 and a potential value of USD 102. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the CL page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-09-27). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

ReduceCL · Fair value $74.0-14.0%

Read full analysis →

Colgate-Palmolive Company (CL)

Our latest published analysis: CL rated Reduce

Price

Financial snapshot

Fair-value bridge

Latest news · CL

Valuation

Profitability

Balance sheet

Trading

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

All CL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CL

Frequently asked questions

등급 이력

Category	Score	Reading
Valuation	3.0
Management	8.5
Balance Sheet	3.5
Profitability	7.0
Revenue Growth	4.5
Risk Assessment	5.0
Competitive Moat	9.0
Earnings Quality	7.5
Capital Efficiency	8.5